A nurse is preparing to administer scheduled intravenous vancomycin to an adult client with MRSA pneumonia. Which interventions should the nurse anticipate? Select all that apply.
Select All That Apply
Choose your responses, then check the answer.
Explanation
Infuse vancomycin no faster than 10 mg/min and for at least 60 minutes, with a longer infusion for larger doses, to reduce the risk of vancomycin infusion reaction (Choice 3). For serious MRSA infection, current consensus guidance favors AUC-guided monitoring with a target AUC24/MIC of 400 to 600 when the MIC is assumed to be 1 mg/L; obtain levels according to the institution's protocol and monitor renal function (Choice 6). Vancomycin and heparin may be incompatible at the same Y-site, so verify compatibility and use a separate line or appropriate flushing when required (Choice 1). Mild flushing and pruritus during a rapid infusion suggest an infusion reaction and do not automatically establish anaphylaxis or a permanent allergy (Choice 2). Monitor serum creatinine and the overall renal course rather than using potassium as the primary toxicity marker (Choice 4). Rapid IV push administration is unsafe (Choice 5).
Vancomycin Safe Administration 1. Infuse over ≥ 60 min (≥ 90-120 min for ≥ 1 g) 2. Dedicated line — incompatible with heparin and many other drugs 3. Trough level 30 min before 4th-5th dose; target 15-20 mcg/mL for serious MRSA 4. Monitor SCr/BUN for nephrotoxicity (especially with concurrent aminoglycosides, NSAIDs, IV contrast, hypovolemia) 5. Watch for ototoxicity — tinnitus, hearing changes (rare with current dosing)
Vancomycin Infusion Reaction (formerly "red man") Histamine release from rapid infusion: flushing of face/neck/upper torso, pruritus, sometimes hypotension. NOT a true allergy. Manage: slow the rate, give diphenhydramine; resume at slower rate.
Memory Tip "SLOW + TROUGH": Slow infusion ≥ 60 min, Labs (creatinine), Otic monitoring, Watch for flushing, TROUGH level before 4th-5th dose.
Caution Trough > 20 → nephrotoxicity risk. Hold and notify provider for new SCr rise > 0.5 mg/dL or 50% above baseline.
ScenarioAdult, MRSA pneumonia, vancomycin 1.5 g IV q12h started yesterday. SCr baseline 0.9 mg/dL. Today receiving 4th dose. Trough drawn 30 min before today's dose.
Pre-Infusion Checks- Verify dose, weight-based- Reconstitute, dilute appropriately, infusion ≥ 60 min (this dose ≥ 1 g → 90-120 min)- Dedicated line; if shared, flush thoroughly- Independent double-check (high-alert? per institution)
During InfusionWatch for flushing, pruritus → if mild, slow the rate + diphenhydramine. If true anaphylaxis (wheezing, hypotension, angioedema) → STOP, epinephrine.
Vancomycin trough monitoring — Serum vancomycin level drawn approximately 30 minutes before a scheduled dose, typically before the 4th or 5th dose to ensure steady state. Target depends on indication: 15-20 mcg/mL for serious MRSA (pneumonia, bacteremia, endocarditis), 10-15 for less serious. Many institutions now use AUC-guided dosing.
Vancomycin infusion reaction — Histamine-mediated reaction from rapid infusion (formerly called red man syndrome). Flushing of face/neck/upper torso, pruritus, sometimes hypotension. NOT a true IgE allergy. Manage by slowing infusion (≥ 60 min, often 90-120) and pretreatment with diphenhydramine. Different from true vancomycin anaphylaxis (rare).
Vancomycin nephrotoxicity — Most important toxicity to monitor. Monitor serum creatinine and BUN regularly. Risk increases with trough > 20, concurrent aminoglycosides or other nephrotoxins (NSAIDs, IV contrast, loop diuretics), older age, dehydration, and prolonged therapy. Hold for SCr rise > 0.5 mg/dL or > 50% baseline; notify provider.